Please enable Javascript to get a taste of that Hopium 👼

AGRX - Financials Overview - Agile Therapeutics Inc

Financials

We've grouped the latest 4 financial reports for AGRX. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2018201920202021
Total Revenue--$749K$4.10M
Cost of Revenue$9.76M$9.00M$282K$10.7M
Gross Margin-$10.9M-$9.00M$467K-$6.62M
Research & Development$9.78M$9.86M$13.5M$6.25M
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income-$19.5M-$18.9M-$49.1M-$71.0M
Interest Income$366K$252K$309K$25.0K
Interest Expense$1.12M-$3.11M$3.91M
Net Interest Incomee-$1.12M$252K-$3.11M-$3.91M
Other Income Expense----
Non-recurring Items----
Other Non-operating Income$395K$252K$309K-
Income before Provision for income taxes-$20.3M-$23.9M-$62.5M-$89.3M
Tax Provision-$477K-$5.30M-$10.6M-$14.4M
Net Income-$19.8M-$18.6M-$51.9M-$74.9M
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT-$19.1M-$18.9M-$49.1M-$71.0M
Balance Sheet2018201920202021
otherNonCurrentAssets----
Assets
Cash, Cash Equivalents & Short-term investments$7.85M$34.5M$54.5M$19.1M
Cash & Cash Equivalents----
Other Short-term Investments--$40.0M-
Receivables----
Inventory--$100K$966K
Other Current Assets$607K$840K$1.45M$2.28M
Total Current Assets$8.46M$35.3M$56.8M$23.9M
PPE$13.9M$14.0M$14.2M$12.4M
Non-current Marketable Securities----
total non-current assets$13.9M$14.0M$16.3M$15.4M
Goodwill----
Other Intangible Assets----
deferred long-term asset charges----
Total Assets$22.4M$49.5M$73.1M$39.3M
Liabilities
Accounts Payable----
Current Debt-$172K$138K$17.0M
Other Current Liabilties$1.34M$1.80M$3.35M$3.56M
Total Current Liabilities$2.22M$3.80M$7.35M$29.3M
Long Term Debt--$16.4M$16.8M
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities----
total non-current liabilities--$16.4M$784K
Total capital lease obligations-$172K$138K$959K
Total Liabilities$2.22M$3.80M$23.7M$30.1M
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock----
Total Shareholders' Equity$20.2M$45.7M$49.3M$9.27M
Total Liabilities and Shareholders' Equity----
Cash Flow2018201920202021
Cash from Operating Activities
Operating Activities-$16.9M-$15.7M-$47.3M-$65.2M
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income-$19.8M-$18.6M-$51.9M-$74.9M
Depreciation----
Change in Liabilities----
Change in Inventory---$6.29M
Change(increase) in Account Receivables----
Change(increase) in Receivables--$865K$668K
Cash from Investing Activities
Investment Activities-$318K-$98.0K-$40.7M$39.5M
Other Investment Activities----
Investments----
Capital Expenditures$318K$98.0K$353K$269K
Cash from Financing Activities
Financing Activities-$10.9M$42.4M$68.0M$30.4M
Other Financing Activities----
Stock Sale and Purchase----
Dividends----
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents-$28.1M$26.6M-$20.0M$4.68M
Change(increase) in Net Income----
Change in Exchange Rate----
Data source(s): Alpha Vantage